Gene: STK31
Official Full Name: serine/threonine kinase 31provided by HGNC
Gene Summary: This gene is similar to a mouse gene that encodes a putative protein kinase with a tudor domain, and shows testis-specific expression. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13686 | STK31 Knockout cell line (A549) | Human | STK31 | 1:3~1:4 | Negative | Online Inquiry |
STK31 Gene Knockout Cell Lines represent a cutting-edge methodological tool designed to facilitate the study of the STK31 gene, a crucial player implicated in various cellular processes and disease states. These cell lines are engineered to lack functional STK31 proteins, enabling researchers to elucidate the gene's role in signal transduction, cell proliferation, and differentiation. The knockout mechanism is precisely orchestrated via CRISPR-Cas9 technology, ensuring high specificity and efficiency in the gene editing process.
The primary function of STK31 Gene Knockout Cell Lines is to provide a platform for loss-of-function studies that unveil the biological pathways and mechanisms regulated by STK31. Researchers can investigate how the absence of this gene influences cellular behavior, responses to drugs, and interactions with other molecular partners, thereby advancing our understanding of its potential implications in disease, particularly in cancer research.
Scientifically, these cell lines hold significant importance for both fundamental research and translational applications. They can be utilized to create disease models, screen for therapeutic targets, and contribute to the development of novel treatments. Their applications span various fields, including oncology, immunology, and regenerative medicine, making them indispensable in modern biological research.
Compared to conventional methods of gene study, such as RNA interference or overexpression systems, STK31 Gene Knockout Cell Lines offer clear advantages in specificity and stability. Researchers benefit from the permanent knockdown of the gene of interest, enabling long-term studies that are critical for understanding chronic conditions.
The value of this product to researchers and clinicians lies in its ability to facilitate groundbreaking discoveries and improve the accuracy of experimental results. By providing a reliable cellular model without STK31 activity, our cell lines empower users to gain insights that may lead to the identification of novel therapeutic strategies.
With a commitment to innovation and scientific excellence, our company delivers high-quality biological products tailored to support the advanced research needs of the scientific community. The STK31 Gene Knockout Cell Lines exemplify our dedication to providing tools that enhance research efficacy and drive progress in biological science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.